Friday, 20 November 2026European Markets

ULTIMOVACS Stock 13.27% Up Before The Weekend

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - The Market ended the session with ULTIMOVACS (ULTI.OL) jumping 13.27% to kr7.17 on Friday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.67% to kr1,319.33, after five consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

ULTIMOVACS's last close was kr6.33, 96.46% below its 52-week high of kr178.60.

About ULTIMOVACS

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.5.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -51.94%.

Moving Average

ULTIMOVACS's worth is way under its 50-day moving average of kr119.29 and way below its 200-day moving average of kr99.42.

Yearly Top and Bottom Value

ULTIMOVACS's stock is valued at kr7.17 at 21:36 EST, way under its 52-week high of kr178.60 and way higher than its 52-week low of kr6.50.

Volume

Today's last reported volume for ULTIMOVACS is 1542190 which is 63.59% above its average volume of 942686.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ULTIMOVACS's stock is considered to be overbought (>=80).

More news about ULTIMOVACS (ULTI.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 22 Mar 2024
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›